Lead Product(s) : Pentamidine
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 06, 2014
Lead Product(s) : Pentamidine
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Pentamidine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Addis Ababa University | University of Gondar | Tigray Regional Health Bureau, Tigray Region | Amhara Regional Health Bureau | Médecins Sans Frontières Netherlands | Leishmania East Africa Platform | Drugs for Neglected Diseases
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 26, 2011
Lead Product(s) : Pentamidine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Addis Ababa University | University of Gondar | Tigray Regional Health Bureau, Tigray Region | Amhara Regional Health Bureau | Médecins Sans Frontières Netherlands | Leishmania East Africa Platform | Drugs for Neglected Diseases
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
